BNP Paribas Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3M | Buy |
676,280
+153,812
| +29% | +$5.08M | 0.05% | 329 |
|
|
2025
Q1 | $21M | Buy |
522,468
+33,106
| +7% | +$1.33M | 0.06% | 331 |
|
|
2024
Q4 | $23M | Buy |
489,362
+161,290
| +49% | +$7.59M | 0.06% | 306 |
|
|
2024
Q3 | $17.3M | Sell |
328,072
-55,970
| -15% | -$2.96M | 0.04% | 333 |
|
|
2024
Q2 | $20.8M | Buy |
384,042
+29,544
| +8% | +$1.6M | 0.05% | 292 |
|
|
2024
Q1 | $24.9M | Sell |
354,498
-112,580
| -24% | -$7.89M | 0.07% | 275 |
|
|
2023
Q4 | $39M | Sell |
467,078
-149,400
| -24% | -$12.5M | 0.11% | 211 |
|
|
2023
Q3 | $18.2M | Buy |
616,478
+187,259
| +44% | +$5.52M | 0.06% | 306 |
|
|
2023
Q2 | $14M | Sell |
429,219
-135,533
| -24% | -$4.42M | 0.04% | 340 |
|
|
2023
Q1 | $19.9M | Sell |
564,752
-34,790
| -6% | -$1.22M | 0.07% | 293 |
|
|
2022
Q4 | $27.5M | Sell |
599,542
-29,257
| -5% | -$1.34M | 0.1% | 240 |
|
|
2022
Q3 | $30.5M | Sell |
628,799
-24,714
| -4% | -$1.2M | 0.12% | 199 |
|
|
2022
Q2 | $25.7M | Sell |
653,513
-139,643
| -18% | -$5.49M | 0.1% | 234 |
|
|
2022
Q1 | $29.2M | Sell |
793,156
-47,445
| -6% | -$1.75M | 0.1% | 239 |
|
|
2021
Q4 | $38.3M | Buy |
840,601
+18,854
| +2% | +$859K | 0.13% | 198 |
|
|
2021
Q3 | $29.4M | Sell |
821,747
-274,057
| -25% | -$9.79M | 0.11% | 223 |
|
|
2021
Q2 | $21.7M | Buy |
1,095,804
+189,082
| +21% | +$3.74M | 0.08% | 298 |
|
|
2021
Q1 | $21.1M | Buy |
906,722
+271,636
| +43% | +$6.32M | 0.09% | 270 |
|
|
2020
Q4 | $13.2M | Buy |
+635,086
| New | +$13.2M | 0.06% | 329 |
|